Is neonatal phototherapy associated with an increased risk for hospitalized childhood bronchial asthma?

Sara Aspberg1, Gisela Dahlquist, Thomas Kahan

  • 1Division of Internal Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden. sara.aspberg@ds.se

Insights

Neonatal jaundice (icterus) and phototherapy may increase the risk of childhood asthma, particularly hospitalized cases. Further research is needed to confirm this association between neonatal factors and asthma development.

Area of Science:

  • Pediatrics
  • Epidemiology
  • Neonatology

Background:

  • Childhood asthma is a significant public health concern.
  • Identifying early-life risk factors for asthma is crucial for prevention strategies.
  • Previous studies have linked various perinatal factors to asthma, but neonatal-specific influences require further investigation.

Purpose of the Study:

  • To investigate the association between fetal and neonatal factors and the risk of developing hospitalized childhood bronchial asthma (asthma).
  • To identify specific neonatal characteristics that may independently predict asthma development.

Main Methods:

  • Population-based register study using Swedish health data (1987-2001).
  • Identified 14,803 children hospitalized for asthma (aged ≥2 years) and compared them with a control group.
  • Utilized Mantel-Haenszel odds ratios (ORs) and Miettinen's test-based confidence intervals (CIs) with adjustments for confounders.

Main Results:

  • Confirmed known risk factors: young maternal age, smoking, low education, diabetes, preterm birth, low birth weight, SGA, C-section, and instrumental delivery.
  • Identified independent neonatal risk factors: sepsis/pneumonia, respiratory problems, neonatal icterus, and phototherapy.
  • Neonatal icterus/phototherapy showed a significant association (OR 1.27, 95% CI: 1.08-1.50), persisting after adjustments and increasing with recurrent hospitalizations.

Conclusions:

  • Neonatal icterus and/or phototherapy are associated with an increased risk of hospitalized childhood asthma.
  • These findings suggest a potential link between specific neonatal conditions and subsequent asthma development.
  • Further research is warranted to explore the mechanisms underlying the association between neonatal icterus/phototherapy and childhood asthma.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: